Darjan Andrejc

Darjan Andrejc has a diverse work experience in the pharmaceutical industry. Darjan began their career in 2008 as a Pharmaceutical Technologist Assistant at Sandoz, where they assisted in the development of solid final dosage formulations. In 2010, they joined the National Institute of Chemistry Slovenia as a Scientific Researcher in Biotechnology, conducting experiments in a GMP environment.

In 2016, Darjan worked as a Medical Representative at Berlin-Chemie AG, providing medical information on clinical studies for cardiac and pulmonary diseases. Darjan then transitioned to the Health Authority for Medicinal Products of Slovenia in 2017 as a GMP/GDP Inspector, leading and accompanying inspections and managing quality defects.

From 2019 to 2022, Darjan worked as a QA Manager at Idorsia Pharmaceuticals Ltd, where they managed QA documents, supported supplier qualification activities, and coordinated risk assessments. Darjan was also involved in the launch of two projects that received marketing authorizations.

Most recently, Darjan joined CUTISS AG in 2022 as a Senior QA Manager, where they co-lead a team to ensure a proactive and phase/appropriate approach to maintaining a Quality Management System. Darjan is responsible for ensuring compliance, managing key QA compliance systems, and contributing to regulatory inspections.

Overall, Darjan Andrejc has a strong background in pharmaceutical quality assurance and regulatory compliance, with experience in various roles within the industry.

Darjan Andrejc's education history begins in 2003 when they enrolled at the University of Ljubljana. Darjan completed their Master of Pharmacy degree at this institution in 2010. Afterward, they continued their academic journey at the University of Ljubljana, pursuing a Doctor of Philosophy - PhD in Biotechnology (Biomedical sciences on Medical Faculty). Darjan successfully achieved this degree in 2017.